A Clinical Study of MIL95 in Advanced Malignancies.

Clinical trial NCT04651348 · UNKNOWN

Trial details

NCT number: NCT04651348
Sponsor: Beijing Mabworks Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2021-01-04
Primary completion: 2022-12-08
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.